药物对比
Acarbose vs Vildagliptin
Acarbose（Precose）与Vildagliptin对比：延缓碳水化合物吸收 vs DPP-4抑制以增强肠促胰素效应。口服2型糖尿病药物，均无黑框警告。
此页面暂无可用的对比维度。
临床背景
This comparison arises for patients with type 2 diabetes considering an alpha-glucosidase inhibitor versus a DPP-4 inhibitor for glycemic control.
结论
Acarbose delays carbohydrate digestion for postprandial control with GI side effects while Vildagliptin inhibits DPP-4 offering glucose-dependent insulin release with fewer GI issues.
全部药物对比